Prophylaxis of Radiation proctitis
Also known as: Proctitis Radiation / Radiation Proctitis / Radiation proctitis (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB01143 | Amifostine | A cytoprotective adjuvant used for reduction in the cumulative renal toxicity in patients with ovarian cancer and moderate to severe xerostomia in patients undergoing post-operative radiation treatment for head and neck cancer. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB01143 | Amifostine | Alkaline phosphatase, germ cell type | target |
DB01143 | Amifostine | Alkaline phosphatase, tissue-nonspecific isozyme | enzyme |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB01222 | Budesonide | 2 | Terminated | 1 |
DB18530 | Bifidobacterium spp. | 2 / 3 | Recruiting | 1 |
DB00130 | L-Glutamine | 2 / 3 | Recruiting | 1 |
DB15823 | Lactobacillus acidophilus | 2 / 3 | Recruiting | 1 |
DB16540 | Lactobacillus delbrueckii bulgaricus | 2 / 3 | Recruiting | 1 |